(Q65001570)

3 July 2019

title

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer. (English)

1 reference

3 July 2019

author name string

Zhou JX

1

1 reference

3 July 2019

Niehans GA

2

1 reference

3 July 2019

Shar A

3

1 reference

3 July 2019

Rubins JB

4

1 reference

3 July 2019

Frizelle SP

5

1 reference

3 July 2019

Kratzke RA

6

1 reference

3 July 2019

publication date

1 April 2001

1 reference

3 July 2019

published in

Lung Cancer

1 reference

3 July 2019

volume

32

1 reference

3 July 2019

issue

1

1 reference

3 July 2019

page(s)

27-38

1 reference

3 July 2019

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

1 reference

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Physical interaction of the retinoblastoma protein with human D cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Function of a human cyclin gene as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Mechanisms of p16INK4A inactivation in non small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

DNA methylation and expression of p16(INK4A) gene in pulmonary adenocarcinoma and anthracosis in background lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Do molecular markers predict survival in non-small-cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900210-5

7 January 2021

10.1016/S0169-5002(00)00210-5

Identifiers

DOI

1 reference

3 July 2019

1 reference

3 July 2019